Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1963 May 1;117(5):755-74.
doi: 10.1084/jem.117.5.755.

Suppression of allergic encephalomyelitis in rats by means of antibrain serum

P Y PATERSON, S M HARWIN

Suppression of allergic encephalomyelitis in rats by means of antibrain serum

P Y PATERSON et al. J Exp Med. .

Abstract

Rats regularly develop evidence of allergic encephalomyelitis (AE) 2 to 3 weeks following sensitization to nervous tissue plus adjuvant. Independent of the severity of AE which occurs, gradual recovery is the rule and by the 6th to 9th week after sensitization rats appear clinically well and microscopic lesions of AE have virtually disappeared. Pooled serum collected from rats 3 or 6 weeks after sensitization contains complement-fixing (CF) antibrain antibodies. Such pooled serum exerts a striking suppressive influence on development of AE when passively administered to rats actively sensitized to nervous tissue. Serum pools which contain CF antibrain antibody suppress the disease. Serum pools lacking CF antibody do not suppress the disease. Serum containing CF antibrain antibody after treatment with 2-mercaptoethanol no longer fixes complement with brain antigen in vitro and no longer suppresses AE in vivo. The data suggest that transfer of protection against AE by passively administered antibrain rat serum is due to an antibrain antibody, possibly the CF antibodies. The meaning of these findings is discussed in terms of the role(s) of circulating antibrain antibody in the pathogenesis of AE.

PubMed Disclaimer

References

    1. J Exp Med. 1960 Aug 1;112(2):293-314 - PubMed
    1. J Immunol. 1962 Jul;89:72-9 - PubMed
    1. J Exp Med. 1953 May;97(5):711-26 - PubMed
    1. J Exp Med. 1961 May 1;113:935-57 - PubMed
    1. Br J Exp Pathol. 1962 Feb;43:1-11 - PubMed